01 1Viatris
01 1CEVIMELINE HYDROCHLORIDE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-21
Pay. Date : 2013-09-12
DMF Number : 24949
Submission : 2011-10-31
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CEVIMELINE HYDROCHLORIDE USP, with a corresponding US DMF Number 24949.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2013, and payment made on September 12, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
